Your morning briefing from CTVNews.ca
 
January 20, 2023

GOOD MORNING

The feds have agreed to bring home multiple women and children detained in prison camps in Syria, a new COVID-19 vaccine that can be inhaled is set to enter Phase 2 human trials and the deal to keep Prime Minister Justin Trudeau in power is contingent on action on some NDP priorities.

Here's what you need to know to start your day.

Canadians to be repatriated

The Canadian government has agreed to bring home six Canadian women and 13 children currently detained in prison camps in Syria, according to Lawrence Greenspon, the lawyer representing them in a federal court case.

Two-party deal

As the Liberals plot out their 2023 policy moves, weighing heavily are commitments Prime Minister Justin Trudeau made to NDP Leader Jagmeet Singh that have to be acted on this year.

David Crosby, 1941-2023

A folk rock pioneer and one of the founding members of The Byrds and Crosby, Stills, Nash & Young, has died. Crosby was 81 years old.

Inhaled COVID vaccine

A new made-in-Canada COVID-19 vaccine that can be inhaled is set to enter Phase 2 human trials.The vaccine is being developed at McMaster University in Hamilton, Ont.

To hike or not

Economists don't believe the Bank of Canada is ready to hit the brakes on its interest rate-hiking cycle just yet, even as signs grow that inflation is easing and the economy is softening.

MUST-SEE VIDEO

New Mexico prosecutor explains decision to charge Alec Baldwin.


ONE MORE THING

Does the polar vortex mean climate change isn't a problem? Not even close.


fb tw insta yt yt yt
Subscribe to our other newsletters
Nightly Briefing 5 Things Capital Dispatch

A curated newsletter on the day’s most important news.

The biggest headlines to start your morning.

A twice-weekly update on the latest from Parliament Hill.

You are subscribed to CTV News as newsletter@newslettercollector.com

You have received this message from CTV News, a Bell Media property.

Bell Media Inc.
9 Channel Nine Ct,
Scarborough, ON M1S 4B5

You can contact us at 1-866-690-6179

Privacy Policy   |   Manage Subscriptions   |   Unsubscribe

© 2022 Bell Media  All rights reserved.
Bell Media